Last updated: April 19, 2024
Sponsor: Sengkang General Hospital
Overall Status: Active - Recruiting
Phase
2/3
Condition
Hemorrhoids
Treatment
Laser Haemorrhoidoplasty (LAH)
Open milligan-morgan conventional haemorrhoidectomy
Clinical Study ID
NCT04329364
2019/2930
Ages 21-90 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- between 21-90 years old
- presents with symptomatic haemorrhoids as evident from clinical assessment
- never had any haemorrhoid-related operations performed on them before
- fit for general anaesthesia
- able to give informed consent
- willing to be randomized
- willing to fill in post-operative questionnaires and be compliant to follow up
Exclusion
Exclusion Criteria:
- Are pregnant
- Are prisoners
- Intellectually, mentally or emotionally deemed not able to provide an informed consentand/or are unable to fill up the post-procedure questionnaires/VAS score
- Have had previous haemorrhoid procedural treatment before (except Rubber BandLigation)
- Declined endoscopic evaluation
- Are on anti-coagulation
- Have history of thrombophilia
- Are on steroids
- Have haemorrhoids which are incidentally found on endoscopy/clinical examination butare asymptomatic from it
Study Design
Total Participants: 128
Treatment Group(s): 2
Primary Treatment: Laser Haemorrhoidoplasty (LAH)
Phase: 2/3
Study Start date:
October 01, 2020
Estimated Completion Date:
June 30, 2025
Connect with a study center
Sengkang General Hospital
Singapore, 544886
SingaporeActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.